Literature DB >> 7543444

Opposing effects of interferon-gamma on iNOS and interleukin-10 expression in lipopolysaccharide- and mycobacterial lipoarabinomannan-stimulated macrophages.

T I Roach1, C H Barton, D Chatterjee, F Y Liew, J M Blackwell.   

Abstract

Previous studies have demonstrated that, like bacterial lipopolysaccharide (LPS), arabinofuranosyl-terminated lipoarabinomannan (AraLAM) from an attenuated strain of Mycobacterium induces potent early gene (c-fos, KC, JE and TNF-alpha) responses in murine macrophages, whereas extensively alpha-Manp capped LAM (ManLAM) from virulent M. tuberculosis do not. In this study we have extended analysis of the influence of mycobacterial LAM on macrophage function by demonstrating that AraLAM (but not ManLAM), like bacterial LPS, is a potent stimulator of inducible nitric oxide synthase (iNOS) expression independent of the autocrine activity of co-stimulated tumour necrosis factor-alpha (TNF-alpha) release. The inability of ManLAM to induce iNOS expression was not due to induction of the 'deactivating' cytokine interleukin-10 (IL-10). Indeed, like LPS, AraLAM was also a potent inducer of IL-10 expression. However, analysis of AraLAM- or LPS-induced responses in the presence of interferon-gamma (IFN-gamma) showed that, whereas IFN-gamma acts as a potent co-stimulus for iNOS, it completely inhibits the IL-10 response. Hence, the presence of IFN-gamma early in infection will have an important immunomodulatory role in determining the macrophage response. These results have important implications for the pathogenesis of virulent and avirulent mycobacteria in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7543444      PMCID: PMC1384032     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  53 in total

1.  CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein.

Authors:  S D Wright; R A Ramos; P S Tobias; R J Ulevitch; J C Mathison
Journal:  Science       Date:  1990-09-21       Impact factor: 47.728

2.  Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha.

Authors:  S J Green; R M Crawford; J T Hockmeyer; M S Meltzer; C A Nacy
Journal:  J Immunol       Date:  1990-12-15       Impact factor: 5.422

3.  Role of inorganic nitrogen oxides and tumor necrosis factor alpha in killing Leishmania donovani amastigotes in gamma interferon-lipopolysaccharide-activated macrophages from Lshs and Lshr congenic mouse strains.

Authors:  T I Roach; A F Kiderlen; J M Blackwell
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

4.  L-arginine-dependent macrophage effector functions inhibit metabolic activity of Mycobacterium leprae.

Authors:  L B Adams; S G Franzblau; Z Vavrin; J B Hibbs; J L Krahenbuhl
Journal:  J Immunol       Date:  1991-09-01       Impact factor: 5.422

5.  Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates.

Authors:  M Denis
Journal:  Cell Immunol       Date:  1991-01       Impact factor: 4.868

6.  IL-10 inhibits cytokine production by activated macrophages.

Authors:  D F Fiorentino; A Zlotnik; T R Mosmann; M Howard; A O'Garra
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

7.  Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates.

Authors:  I E Flesch; S H Kaufmann
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

8.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.

Authors:  R de Waal Malefyt; J Abrams; B Bennett; C G Figdor; J E de Vries
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

9.  Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta).

Authors:  J S Silva; D R Twardzik; S G Reed
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

10.  Macrophage deactivation by interleukin 10.

Authors:  C Bogdan; Y Vodovotz; C Nathan
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

View more
  15 in total

1.  A network map of Interleukin-10 signaling pathway.

Authors:  Renu Verma; Lavanya Balakrishnan; Kusum Sharma; Aafaque Ahmad Khan; Jayshree Advani; Harsha Gowda; Srikanth Prasad Tripathy; Mrutyunjay Suar; Akhilesh Pandey; Sheetal Gandotra; T S Keshava Prasad; Subramanian Shankar
Journal:  J Cell Commun Signal       Date:  2015-08-08       Impact factor: 5.782

2.  An unusual pro-inflammatory role of interleukin-10 induced by arabinosylated lipoarabinomannan in murine peritoneal macrophages.

Authors:  Nivedita Majumder; Ranadhir Dey; Ram Kumar Mathur; Sriparna Datta; Madhumita Maitra; Sanjukta Ghosh; Bhaskar Saha; Subrata Majumdar
Journal:  Glycoconj J       Date:  2006-12       Impact factor: 2.916

3.  Interferon-gamma differentially regulates interleukin-12 and interleukin-10 production in leprosy.

Authors:  D H Libraty; L E Airan; K Uyemura; D Jullien; B Spellberg; T H Rea; R L Modlin
Journal:  J Clin Invest       Date:  1997-01-15       Impact factor: 14.808

4.  A role for interleukin-17A in modulating intracellular survival of Mycobacterium bovis bacillus Calmette-Guérin in murine macrophages.

Authors:  Wai Lim Ling; Liang Jie Wang; John C H Pong; Allan S Y Lau; James C B Li
Journal:  Immunology       Date:  2013-11       Impact factor: 7.397

5.  Role of gamma interferon in cellular immune response against murine Encephalitozoon cuniculi infection.

Authors:  I A Khan; M Moretto
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

6.  Increased antimycobacterial immunity in interleukin-10-deficient mice.

Authors:  P J Murray; R A Young
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

7.  Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice.

Authors:  F Obermeier; G Kojouharoff; W Hans; J Schölmerich; V Gross; W Falk
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

Review 8.  Development of an asthma vaccine: research into BCG.

Authors:  C B Scanga; G Le Gros
Journal:  Drugs       Date:  2000-06       Impact factor: 9.546

9.  CD36 deficiency attenuates experimental mycobacterial infection.

Authors:  Michael Hawkes; Xiaoming Li; Maryanne Crockett; Angelina Diassiti; Constance Finney; Gundula Min-Oo; W Conrad Liles; Jun Liu; Kevin C Kain
Journal:  BMC Infect Dis       Date:  2010-10-15       Impact factor: 3.090

10.  Exposure to bacterial products renders macrophages highly susceptible to T-tropic HIV-1.

Authors:  M Moriuchi; H Moriuchi; W Turner; A S Fauci
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.